Navigation Links
First Ever Patch Drug To Treat Parkinsons Symptoms Approved

The U.S. Food and Drug administration on Wednesday approved a new patch-drug, the first ever medicine to treat the symptoms of Parkinson's disease . Known by the name Neupro, the once-daily patch is manufactured by Schwarz Pharma AG. The patch contains a drug called rotigotine, which has not been sold before in the United States.

Parkinsons disease (PD) is a degenerative disorder of the central nervous system that often impairs the sufferer's motor skills and speech. It is characterized by muscle rigidity, tremor, a slowing of physical movement and, in extreme cases, a loss of physical movement.

In a healthy brain, certain brain cells produce a chemical called dopamine, which helps the brain coordinate the body's movements while in the patients who suffer from Parkinson's, dopamine-producing brain cells cannot survive. Dopamine is crucial for the communication between cells that control muscle movement hence the sufferers of PD are often seen trembling.

Accordingly, the rotigotine present in the Neupro patch works by activating dopamine receptors in the brain, imitating the neurotransmitter's effect. The FDA determined the effectiveness of Neupro's by three studies that included 1,154 patients with early Parkinson's disease who were not taking other Parkinson's medications.

Rotigotine is a member of a class of drugs called dopamine agonists, which mimic dopamine's effects.

Other Parkinson's disease drugs are given orally. Those drugs are effective, but some patients experience a wearing-off effect at the end of each dose. The Parkinson's patch is designed to solve that problem.

However, the patch also has some side effects that include skin reactions at the patch site, dizziness, nausea, vomiting, drowsiness and insomnia. Also, the patient using this patch can experience a sudden onset of sleep while doing some activities like driving or operating machinery. Other side effects also include hallucinat ions and decreased blood pressure when standing up.

An estimated 1 million people in the U.S. have Parkinson's, with an additional 60,000 cases diagnosed each year.


'"/>




Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. First human clone is near
4. First Artificial Heart patient has Major setback
5. First head-to-head trials of once weekly Fosamax and Actonel therapies
6. WHO Declares Vietnam First Country to Control SARS
7. Russia Reports First SARS Case
8. Hope for First New Melanoma Treatment in Decades
9. First global SARS meet opens
10. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
11. Hyderabad To Have Asia’s First Catheter Making Uni
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/25/2016)... Newark, NJ (PRWEB) , ... May 25, 2016 ... ... the Kids’ Oral Health Program (KOHP), a $500,000 two-year pilot initiative to improve ... includes funding to support professional development for health care providers and promote best ...
(Date:5/25/2016)... ... May 25, 2016 , ... New studies published today by ... across 15 states. The outcomes examined in these studies include recovery of physical ... satisfaction with medical care. , “The goal of the studies is to provide ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... Cheryl Bowker ... has to bestow: the Dick McKenna Good Hands Legacy Award. McKenna ran one of ... others which continues to inspire all those who knew him. The award named for ...
(Date:5/25/2016)... ... May 25, 2016 , ... Casa Velas, an adults-only boutique hotel in ... to complement its new wellness suites . The two 1,350 sq. ft. suites ... of special services and insuite amenities, from a custom soap selection and in-suite exercise ...
(Date:5/25/2016)... ... 2016 , ... Laser Skin & Wellness Center is excited to ... of female aging. The Juliet™ procedure helps to reverse the effects ... laxity, itchiness and pain have reported real relief from these and other problems by ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... India , May 25, 2016 ... Review, H1 2016"market research report that provides an ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ... It also reviews key players involved in the ...
(Date:5/24/2016)... , May 24, 2016  Diana Russell suffers ... her organs from the inside out.  This disease has ... dependent on her children and grandchildren to leave her ... wheelchair, Diana,s family cannot haul the wheelchair.  So if ... the car, and Diana is left to wait for ...
(Date:5/24/2016)... 2016 The innovator of ... , s first dual therapy stent, introduces catheters ... OrbusNeich, a global company specializing in the provision ... include products to treat peripheral artery disease. The JADE™ ... devices for lower limb and arteriovenous (AV) fistula intervention. ...
Breaking Medicine Technology: